news CRISPR-Cas9 technology used to study hereditary forms of cancer 14 September 2017 | By Dr Zara Kassam (Drug Target Review) Researchers have developed a method, based on CRISPR-Cas9 technology in organoids, to study the genetic cause of hereditary forms of cancer...